HIV i-Base news story
When i-Base reported several GLP-1 studies in people living with HIV from CROI 2024, a discussion was included about whether anecdotal reports of breaking the dopamine reward pathway associated with reduced craving for food might help reduce dependence on chemsex drugs which currently have no effective treatment to support and manage withdrawal.
A new paper in the BMJ from a large observational database study now adds substantial data to this potential benefit for use in substance use disorder.
The results showed a clear and consistent reduction in the use of cannabis, cocaine, nicotine, opioid and other substances, together with reduced hospital visits, mortality and suicide.
Read the full news story here.
Source : HIV i-Base
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.